P. Bamonti, R. Weiskittle, A. Naik, J. Bean, J. Moye
{"title":"Depression Moderates Physical Functioning Over Time in Survivors of Cancer","authors":"P. Bamonti, R. Weiskittle, A. Naik, J. Bean, J. Moye","doi":"10.1097/01.REO.0000000000000275","DOIUrl":null,"url":null,"abstract":"Background: Cancer survivors are at risk for declines in physical functioning (PF). The strongest predictor of PF is prior PF. Clinically significant depression predicts declines in PF; however, the extent to which depression symptoms moderate the association between self-reported and performance-based measures of PF over time is unknown. Objective/Purpose: To examine whether level of depression symptoms in cancer survivors moderates the association of repeated self- and performance-based measures of PF at 6 and 18 months after cancer diagnosis. Methods: Prospective, observational study with assessment at 6 (T1), 12 (T2), and 18 months after cancer diagnosis (T3). Setting and Patients: Community-dwelling US veterans with newly diagnosed head and neck, esophageal, gastric, or colorectal cancers. Measurements: Measures included demographics, cancer variables (type, stage, severity, and treatment), depression symptoms (Patient Health Questionnaire-9 [PHQ-9]), Short Physical Performance Battery (SPPB), and self-reported PF (Patient-Reported Outcomes Measurement Information System-29 [PROMIS-29]). Results: Using hierarchical regression models, after adjustment for covariates, depression symptoms at T2 moderated the relationship between performance-based PF, SPPB (β = −0.24, P = .001) but not self-reported PF, PROMIS (β = −0.14, P = .05). In moderation analyses, SPPB T1 was only related to SPPB T3 when the PHQ-9 score was less than 9. Limitations: Majority White, male participants, did not measure chronicity of depression. Conclusions: Depression symptoms moderate the relationship of performance-based PF from baseline to 18 months.","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"8 1","pages":"E98 - E105"},"PeriodicalIF":1.0000,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rehabilitation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.REO.0000000000000275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Cancer survivors are at risk for declines in physical functioning (PF). The strongest predictor of PF is prior PF. Clinically significant depression predicts declines in PF; however, the extent to which depression symptoms moderate the association between self-reported and performance-based measures of PF over time is unknown. Objective/Purpose: To examine whether level of depression symptoms in cancer survivors moderates the association of repeated self- and performance-based measures of PF at 6 and 18 months after cancer diagnosis. Methods: Prospective, observational study with assessment at 6 (T1), 12 (T2), and 18 months after cancer diagnosis (T3). Setting and Patients: Community-dwelling US veterans with newly diagnosed head and neck, esophageal, gastric, or colorectal cancers. Measurements: Measures included demographics, cancer variables (type, stage, severity, and treatment), depression symptoms (Patient Health Questionnaire-9 [PHQ-9]), Short Physical Performance Battery (SPPB), and self-reported PF (Patient-Reported Outcomes Measurement Information System-29 [PROMIS-29]). Results: Using hierarchical regression models, after adjustment for covariates, depression symptoms at T2 moderated the relationship between performance-based PF, SPPB (β = −0.24, P = .001) but not self-reported PF, PROMIS (β = −0.14, P = .05). In moderation analyses, SPPB T1 was only related to SPPB T3 when the PHQ-9 score was less than 9. Limitations: Majority White, male participants, did not measure chronicity of depression. Conclusions: Depression symptoms moderate the relationship of performance-based PF from baseline to 18 months.